Presentation ACC 2020 VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel Presenter: William Hiatt March 29, 2020
News Conference News ACC 2020 PARTNER 3: TAVR Now Noninferior to Surgery at 2 Years in Low-Risk Patients Yael L. Maxwell March 29, 2020
News Opinion Conversations in Cardiology Conversations in Cardiology: Uncovered Struts on OCT After 12 Years? March 27, 2020
News Daily News More Support for DOAC-Based Double Therapy After PCI for A-fib Patients Todd Neale March 16, 2020
News Daily News Potent Antithrombotic Therapy Cuts Spontaneous MI After PCI for ACS Yael L. Maxwell March 10, 2020
News Daily News New ABCD-GENE Score Taps Clinical, Genetic Factors to ID Clopidogrel Nonresponders Yael L. Maxwell March 06, 2020
Podcast TCTMD Talking Points MODEL U-SES: 3-Month DAPT in Patients at High Bleeding Risk Treated With a Bioabsorbable-Polymer SES March 04, 2020
News Daily News Validated ARC-HBR Criteria Highlight ‘Eye-opening’ Proportion of PCI Patients at Risk Yael L. Maxwell March 03, 2020
News Daily News New Meta-analysis Supports NOAC Plus P2Y12 Inhibitor for PCI in A-fib Shelley Wood February 28, 2020
News Daily News Bioprosthetic Valve Thrombosis Rare but Not Benign: New Insights Yael L. Maxwell February 28, 2020
Presentation JIM 2020 Optimized DES for High ischemic risk & HBR patients: when efficacy and safety converge into one need Presenter: Marco Valgimigli February 13, 2020
Presentation JIM 2020 Ticagrelor Monotherapy Is the Right Choice! Presenter: Roxana Mehran February 12, 2020
Presentation BIT 2020 Dual Antiplatelet therapy: How Long to Continue after PC Presenter: Baren Chakraborty February 02, 2020
Presentation Controversies and Advances 2019 Optimal DAPT Strategies: Lessons Learned, Global Leaders, TWILIGHT, and More Presenter: Roxana Mehran November 15, 2019
Presentation Cardiovascular Interventions 2019 DAPT: Hot Topics in 2019 Presenter: Dean J. Kereiakes November 01, 2019